Affymax Inc (OTC Pink - Limited Information:AFFY)
| 0.146 Data as of Jan 26 |  +0.0045 / +3.18%Today’s Change | 0.05 Today|||52-Week Range 0.65 | +45.42% Year-to-Date |
Latest AFFY News | Press Releases
No recent news for Affymax Inc.
Today’s Trading
| Previous close | 0.14 |
| Today’s open | 0.15 |
| Day’s range | 0.13 - 0.15 |
| Volume | 70,415 |
| Average volume (3 months) | 172,102 |
| Market cap | $5.3M |
| Dividend yield | -- |
Data as of 01/26/2015
Growth & Valuation
| Earnings growth (last year) | +84.82% |
| Earnings growth (this year) | -79.49% |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | -98.55% |
| P/E ratio | NM |
| Price/Sales | 21.34 |
| Price/Book | -- |
Competitors
| No competitors data available. |
Financials
| Last reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $1.4M |
| Annual profit (last year) | -$14.4M |
| Net profit margin | -1,053.62% |
Profile
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer & Director Richard M. Brenner |
President J. Weston Rose |
Corporate headquarters Cupertino, California |
Forecasts
.